Uses and advantages of CRISPR/Cas genetic edition in yeasts

This review summarizes the use of CRISPR system in yeasts, identifying advantages and 14 disadvantages of its applications. 39 articles were evaluated including 12 articles that discussed the 15 advantages of new CRISPR systems that improved the initial system, and another 27 were 16 evaluated, among these: three were applications in Cryptococcus neoformans, four in candida sp., three 17 in Schizosaccharomyces pombe, nine in Saccharomyces cerevisiae, four in Yarrowia lipolytica, and four in 18 industrially important yeasts such as Pichia pastoris and Saccharomyces pastorianus. It was concluded 19 that the CRISPR system is one of the most versatile genetic editing systems available nowadays. It 20 can be applied in different organisms for several effects including gene knock-outs, performing 21 point mutations, gene expression, or even applying multiple edition operations in several genes. 22 However, we recognize that numerous studies lack a control group of the mutated strains, which 23 leaves many questions unanswered. For instance, the extent and precision of this techniques, it also 24 represents a risk to biosecurity standards. Therefore, this review shows the compilation of CRISPR 25 system information, which could be used to generate different alternatives in the industry and 26 clinical fields 27


Introduction 45
In the past, invasive fungal infections were rare enough to be thought of as unimportant. However,46 yeasts are able to colonize different environments rich in carbon compounds [1]. The study of 47 pathogenic fungi is of great importance due to the increase of clinical cases and the few available 48 antifungals. Additionally, there are weaknesses in the spectrum, potency, and pharmacokinetics of 49 many therapeutic compounds. Research on the study of these pathogens focuses on their 50 pathogenicity, virulence, and differentiation of fungal cells from mammalian host cells, due to their 51 great similarity [2]. Yeasts are also known for their industrial applications which include food 52 production and drug development. The genus with greater industrial use is Saccharomyces, it is also 53 a frequent model for biotechnological studies [3]. 54 The CRISPR system (clustered regularly interspaced short palindromic repeats) was identified as a 55 defense mechanism against exogenous DNA molecules that could affect and alter the cell's DNA, 56 such as phage or plasmid infections and it's thought of as an adaptive immunity system in 57 prokaryotes. [1]. Over the years, many studies were conducted to understand the function of the 58 system in prokaryotes and the structures of the molecules involved in this system. It was not until 59 2012 that Jennifer Doudna a Canadian researcher and Emmanuelle Charpentier a French researcher 60 reinvented the CRISPR system and repurposed it as a tool for genetic engineering [2]. This system 61 has brought a revolution upon contemporary biology in the modification of genetic information. 62 The CRISPR-CAS system is divided into 2 classes; those of class 1 are those that need a large complex 63 of proteins that carry out the action of DNA degradation through a sequence of guide RNA. Those 64 of class 2 are systems that need a single effector endonuclease protein guided by an RNA to carry out 65 the neutralization of the invasive genome. This is the case of the CRISPR-Cas9 and CRISPR-Cpf1 66 system [3]. Cas9 endonuclease is the most used in genetic editing for Eukaryotic microorganisms 67 such as yeasts. The class 2 system is composed of an endonuclease (Cas9 or Cpf1), a short sequence 68 of RNA and the sequence PAMs short DNA sequences (from 3 to 5 bp) called protospacer adjacent 69 motifs [4]. The endonuclease has two lobes: a) recognition system (REC), which is divided into two 70 domains REC1 and REC2, and b) nuclease activity system (NUC), it has the RuvC, HNH and PI 71 domains recognized by the PAM sequence in the DNA sequence [5]. This endonuclease protein 72 performs its activity using the RuvC and HNH domains three nucleotides upstream of the PAM 73 sequence. The guide RNA (sgRNA) consists of a chimeric RNA that retains two fundamental 74 characteristics: a 5 'sequence that determines the DNA target site by pairing Watson-Crick bases 75 (crRNA) and a 3' duplex RNA structure that binds to Cas9 (tracrRNA) [6]. In this review, we describe 76 the application of this system in two species of yeasts of clinical importance, Candida sp, and 77 Cryptococcus neoformans, as well as industrially important species Saccharomyces cerevisiae, Yarrowia 78 lipolytica, and Schizosaccharomyces pombe. 79 Candida Sp is a genus of yeasts and is the most common cause of fungal infections worldwide; This 83 opportunistic infection has a global incidence of around 700,000 cases per year [4]. Although the 84 genus has around 20 human pathogenic species, the CRISPR-Cas9 system to date has been used in 85 only three species of them: C. albicans, C. glabrata, and C. parapsilosis. 86 The CRISPR-Cas9 system was used to modify the genes ADE2, MET15 and SOK2 in C. glabrata, which 87 were located in different chromosomes. The study compared with the application of a SAT1 cassette, 88 a more stablished method of genetic editing. They demonstrated that the CRISPR system is three 89 times more efficient compared to the alternative method of genome editing [5]. The efficiency of 90 CRISPR-Cas9 was not homogenous between all target genes, it was higher for MET15 compared to 91 ADE2 for example. In addition, it is known that efficiency varies in the same target gene depending 92 on the sgRNA sequence used [6]. 93 In other study, the technique was applied to generate knock-out mutations in two genes of C. glabrata 94 which were thought to be associated with the infection process. After successfully performing the 95 desired mutations with a CRISPR-Cas9 system, the mutants were evaluated in the animal infection 96 model D. melanogaster. Their results show the mutants were less virulent than the WT strains, 97 concluding that these two genes must participate in the infection process of C. glabrata in vivo. [7]. 98 The development of modifications in the CRISPR-Cas9 system is frequent. These modifications 99 depend to a great extent on the known genotypic characteristics of the microorganism. In C. 100 parapsilosis an editing system was developed that consisted of a single step of transformation, 101 expressing the CAS9 gene only when the plasmid was present. in addition, this modification 102 allowed to easily eliminate the transformed strains. It is the first system applied in C. parapsilosis 103 using a marker of resistance to nourseothricin in which they published the genes (URA3 and 104 ADE2) by consecutive transformation with two plasmids expressing different sgRNAs to increase 105 the efficiency of gene editing. This gene editing/deletion system could be easily used and could 106 be applied to generate a large number of genetic knock-outs [8]. 107 Cryptococcus neoformans: Cryptococcosis is an opportunistic fungal infection, acquired by the 108 inhalation of fungal propagules present in the environment; is a potentially fatal infection that affects 109 the lungs and the central nervous system (CNS) in immunosuppressed and immunocompetent 110 individuals [9]. The infection is caused by two species, namely: 1) Cryptococcus neoformans var. grubii 111 (serotype A), var. neoformans (serotype D) and a hybrid corresponding to serotype AD and 2) 112 Cryptococcus gattii (serotypes B and C). These species present phenotypic, genotypic and 113 epidemiological differences, as well as in their geographic distribution, in addition, it is a mycosis 114 that presents tropism by the CNS causing meningitis, different virulence factors have been described, 115 implicated in pathogenicity as the capsular size and the production of melanin [10]. Therefore, several 116 investigations have focused on the establishment of the CRISPR-Cas9 system to carry out the selective 117 elimination of virulence and pathogenicity genes in Cryptococcus neoformans. 118 This yeast has a low frequency of homologous recombination, especially for strains of serotype D 119 4 of 16 [11], which has hindered molecular genetic studies in the past. In 2016 Arras S., and collaborators 120 evaluated the use of CRISPR Class 2 for the study of pathogenicity in Cryptococcus neoformans. 121 Initially, they expressed a derivative of Streptococcus pyogenes nuclease Cas9 in C. neoformans and 122 showed that it has no effect on growth, in addition, they evaluated the production of virulence factors 123 in a murine model. They tested CAS9 in combination with multiple self-cleaving guide RNAs 124 targeting the ADE2 gene encoding phosphoribosilaminoamidazole carboxylase. This revealed that 125 CRISPR functionality in C. neoformans depends on the CAS9 construct being stably integrated into 126 the genome, whereas the transient expression of the guide RNA is enough to increase the rates of 127 homologous recombination. This highlights the versatility of this genetic system. Furthermore, the 128 presence of CRISPR nuclease does not influence virulence in a murine model, they successfully 129 demonstrated that this system is compatible with pathogenicity studies in C. neoformans [12]. 130 When the CRISPR-Cas9 system persists in the host cells, cytotoxicity effects may occur, which could 131 block the performed genetic manipulation. This system is a powerful method to perform directed 132 mutagenesis in organisms that present low recombination frequencies and for functional genomic 133 studies. Wang Y., and collaborators reported a method to spontaneously eliminate the CRISPR-Cas9 134 system without affecting its robust editing function. They expressed the unique guiding RNA under 135 the driver of an endogenous U6 promoter and the Cas9 endonuclease optimized in human codon 136 with an ACT1 promoter. This system efficiently generated gene alteration through homology-137 directed repair by electroporation in yeasts, spontaneous elimination of the system was demonstrated 138 through a CRISPR-Cas9 expression cis arrangement, allowing the validation of genetic functions 139 through subsequent complementation and has the potential to minimize the effects outside the target 140 [13]. 141 The biobalistic transformation in C. neoformans, is a tool used for editing the genome where the 142 introduced DNA is inherited in a stable manner, the transformation efficiency and the homologous 143 integration rate is low (approximately 1-10%). The development of Transient CRISPR -Cas9 together 144 with the electroporation system (TRACE) proved useful to increase the rate of transformation since 145 it efficiently integrated new material into the genome due to double-strand breaks created in specific 146 sites by the CRISPR-Cas9 system and the high transformation efficiency of electroporation. This 147 system can effectively eliminate multiple genes in a single transformation, as well as insert DNAs 148 into a designated genetic site without any homologous sequence, which opens many other 149 applications [14]. CRISPR can be used as a tool for the interruption of genes of high efficiency in 150 C. neoformans, it is a useful system to understand this organism and its pathogenicity. 151

Yeasts of industrial importance in biotechnological processes 152
Saccharomyces cerevisiae: It is the most used yeast in industrial processes, followed by S. bayanus and 153 S. pastorianus. In addition, it is the best studied yeast both in its physiological and genetic 154 characteristics, it was even the first Eukaryotic cell to be sequenced [15]. In the industry editing of its 155 genome has been implemented in the past to optimize processes among other applications. Studies 156 have been conducted using the CRISPR-Cas9 technology to reduce production of ethyl carbamate yeast. It has also been used to perform a "knock out" of the CAR1 gene involved in the synthesis of 159 the EC. Process, leaving no antibiotic marker genes or any residual sequence in the vicinity of the 160 CAR1 gene. To inactivate the gene, they introduced a nonsense mutation in the start codon of glycine 161 (Gln) transforming it into a stop codon (TAA) by homologous recombination and designed another 162 experiment that performed the elimination of the traditional NHEJ, eliminating 1002 bp of the gene. 163 To achieve their goal they used two plasmids, one containing the CRISPR system and the other 164 containing the sgRNA. They demonstrated that CRISPR-Cas9-mediated inactivation of the CAR1 165 gene led to a significant reduction in the specific activity of arginase, urea and CD. Furthermore, 166 when comparing the phenotype of the mutants with the wild-type strains, they did not observe 167 statistically significant differences in the growth of the yeast in the culture, nor in the percentage of 168 glucose consumption and ethanol production, which shows that the mutation did not affect the 169 industrial yield of the production, and on the contrary, it reduced the levels of CE by 60% in culture 170 [16]. 171

172
In recent years, new CRISPR designs have been generated in S. cerevisiae. Dashko S and collaborators 173 in 2018, implemented a new family of programmable endonucleases by CRISPR-Cas class II. Using 174 the constitutively expressed endonuclease Cpf1 of Francisella novicida (Fn Cpf1), RNA cleavage of 175 DNA guided by specific genomic loci can mediate. When evaluating this nuclease, they showed that 176 it is not toxic to the yeast and does not interfere with the growth in the culture medium. They 177 determined that the PAM sequence that recognizes this endonuclease is TTN and that Fn Cpf1 is able 178 to perform a directed edition guided by a crRNA and in turn perform point mutations in the ADE2 179 gene by inserting a stop codon. Fn Cpf1 showed an efficiency of up to 100% for the repair of DNA 180 recombination [17]. 181 A novel method for the editing of the genome by CRISPR-Cas9 in S. cerevisiae, consists of introducing 182 a cut-off site in a specific genomic location, followed by the integration of a sequence edited in the 183 same location in a way without scars. They published sequences of the promoter GAL1 and GAL80, 184 they managed to over-express both genes in the yeast, and they showed that the production of agrosa 185 was proportional to the fluorescence emitted by the marker, to achieve this method they had to insert 186 the PAM sequence in the region in a synthetic way. close to the promoter to achieve that the CRISPR 187 system will identify the site in which it should be inserted to stimulate the promoter and overextend 188 the gene [18]. Protocols have also been developed that produce integrations without scars and 189 without DNA markers using a 20 bp sgRNA immediately following the PAM (NGG) sequence [19]. 190 The CRISPR-Cas9 multiplex system was used for the genome engineering of up to 5 different 191 genomic loci in a single transformation step in the yeast, with this methodology. Jakočinas T et al;in 192 2015, managed to overexpress 41 times the mevalonate, an important intermediate metabolite in 193 cholesterol biosynthesis in mutated strains, which makes this methodology a useful tool to increase 194 the production of an industrial molecule [20]. In addition, libraries of high efficiency integration 195 plasmids have been generated to be implemented in the CRISPR-Cas9 system. The DOE Joint 196 BioEnergy Institute, Emeryville of California used a set of cloning-free tools that allows rapid and 197 easy genetic modification of strains in S. cerevisiae, using different plasmids, which presented an 198 efficiency above 95% in 23 genomic loci characterized. The toolkit described in this paper provides a 199 rapid approach to examine multiple gene expression contexts simultaneously [21]. 200 In Denmark they developed kit with EasyClone-MarkerFree vectors using the CRISPR / Cas9 system 201 that facilitates the integration of linearized expression cassettes at defined genomic loci, expressing 202 the (sgRNA) from a set of RNAG helper vectors. Using that set of genomic engineering vectors, 203 simple inserts are obtained with 90-100% and triple with 60-70% focusing efficiency. The EasyClone-204 MarkerFree vector toolkit can be used to simultaneously enter one to three integration cassettes into 205 the genome of S. cerevisiae, without the use of selection markers. Integration cassettes can be 206 constructed for overexpression of one or two genes per integration site; In that study, they 207 successfully integrated up to six genes in a single transformation with a targeting efficiency of 60 to 208 70% [22]. 209 Using the CRISPR-Cas9 system, they integrated by homologous recombination (HR) the XYL1, XYL2 210 and XYL3 genes in the loci PHO13 and ALD6 (involved in the production of acetate), to achieve the 211 overexpression of heterologous genes and the cancellation of endogenous genes simultaneously in 212 strains of S. cerevisiae. For the construction of the mutated strain, they used the sgRNA directed to 213 PHO13 and ALD6 sequentially to replace the genes; in the study they suggest that the sequential 214 integration process can be shortened by a transformation with a plasmid carrying both sgRNA 215 together using multiplex methods. All of the above was carried out in order to generate at an 216 industrial level strains that have higher levels of fermentation and that do not represent a public 217 health hazard, since they do not present resistance genes inserted in the mutation process [23]. 218 S. cerevisiae, has been used in biotechnological processes, an example of this is the evaluation to the 219 resistance to an antiparasitic against the malaria of the family spiroindolonas, the disadvantage with 220 this medicine is that it becomes less active by mutations in an ATPase type P of the parasite. To verify 221 this pattern in the parasite and that the mutations in the P-type ATPase enzyme confers resistance, 222 they used the cellular model of S. cerevisiae, mutated (using CRISPR) the gene that encodes a P-type 223 ATPase (ScPMA1 and ScYRR1) and exposed the cells mutated to spiroindolones (KAE609) to see if 224 they acquired the resistance. These experiments confirmed that mutations in ScPMA1 and ScYRR1 225 cause a 2.5 fold increase in resistance to KAE609, however, ScYRR1 does not appear to be the main 226 target of KAE609. On the other hand it was shown that the ScPMA1 gene mutation is the target 227 molecule of a KAE609 and its mutation is directly related to the resistance [24]. 228 CRISPR in S. cerevisiae, is a very useful system at an industrial level, it has been implemented for the 229 editing of the genome with different approaches, the expression of genes that produce a harmful 230 molecule have been inhibited, this technique was also used in the overexpression of genes and in 231 bioengineering. S. cerevisiae, whose genome and functionality of its genes are well known, is a 232 cellular model, very useful for the design of new CRISPR variant methodologies that allow multiplex 233 mutation and open the possibility of generating more profitable strains for the industry in short time 234 and in a very simple way. 235 Yarrowia lipolytica: This yeast has become an interesting model due to its ability to store large 236 concentrations of lipids in its interior and its ability to secrete proteins to produce valuable 237 biochemical products at an industrial level [25]. The work in this yeast has focused on its 238 physiological, metabolic and genomic characteristics, specifically in the secretion of proteins, for the 239 use of hydrophobic substrates and the biogenesis of the peroxisome, in addition, of the study of 240 molecules involved in dimorphism, in understanding the Mitochondrial complexity, the biogenesis 241 of the lipid body and lipid homeostasis, advances in the study of molecular biology have been made 242 by explaining the splicing of introns and the alternative splice, among others [26]. 243 Being a microorganism completely sequenced and with great industrial advantages, studies have 244 been carried out in which the CRISPR gene editing technique has been implemented to mutate 245 specific genes that improve the production of certain compounds in this yeast. In China, they 246 implemented the CRISPR system to edit the genome with a single plasmid (pCAS1yl or pCAS2yl) by 247 homologous recombination (RH) and non-homologous recombination (NHEJ) for the TRP1 and 248 PEX10 genes [27]. They demonstrated that the highest percentage of efficiency of the system occurred 249 on day 4 of growth, they achieved a simultaneous double and triple gene editing with the plasmid 250 pCAS1yl by NHEJ. The system with the plasmid pCASyl was successful in different strains of Y. 251 Lipolytica, therefore, this system was more efficient than traditional methods of genome editing and 252 facilitated synthetic biology, metabolic engineering and functional genomic studies. 253 Zhang J Lai and Col in 2018, designed a new CRISPR system called CRISPRi multiplex system for the 254 repression of multiple genes in a single step, in Y. Lipolytica, using the Golden-brick assembly method 255 that can assemble different parts without the Initial PCR procedure, which prevents the introduction 256 of new errors in the PCR amplification process and only needs two restriction enzyme sites so that 257 all parts can be assembled in one step [28]. For the design of the CRISPRi system four repressors were 258 used: Cpf1 deactivated with DNase (dCpf1) from Francisella novicida, Cas9 deactivated (dCas9) from 259 Streptococcus pyogenes and two fusion proteins (dCpf1-KRAB and dCas9-KRAB); In addition, ten 260 gRNAs that were linked to different regions of the GFP gene (green fluorescent protein) were 261 designed and the results indicated that there was no clear correlation between the efficiency of 262 repression and the target sites, regardless of which repressor protein was used. In order to rapidly 263 produce strong gene repression, a multiplex sgRNA strategy was developed in which a high 264 repression efficiency of 85% (dCpf1) and 92% (dCas9) was achieved in a short time by making three 265 different gRNAs towards the GFP gene simultaneously. 266 In this same study, they repressed plural genes vioA, vioB and saw simultaneously and the gene saw 267 using the CRISPRi multiplex system in Y. lipolytica. To test the effectiveness of the system, they 268 constructed a VioABE strain containing the protodeoxy-violaceinic acid route (PVA, a pigment 269 derived from tryptophan and its content can be quantified by absorbance) using the dCpf1-Multi and 270 dCas9-Multi vectors, with simple sgRNA and with sgRNA multiplex (3 sgRNA). The transformation 271 was evaluated by PVA in which it was evidenced that when repressing only vioE, the absorbance 272 was reduced to 60% and 40% with the protein dCpf1 and the protein dCas9 respectively, the CRISPRi 273 multiplex system was feasible to implement the repression of multiple genes. 274 Several protocols have been generated for the genetic editing of Y. lipolytica. In 2016b Jassop et al.,

275
Created a new genetic tool Easy-Clone YALI, which allows the construction of genetically modified 276 strains with high efficiency in a simplified way in Y. lipolytica through the CRISPR / Cas9 technology. 277 Modulates gene expression with the integration of cassettes in intergenic sites IntC_2, IntC_3, IntD_1, 278 IntE_1 and IntE_3, in addition, did not affect the growth of yeast [29]. 279 In yeast Y. Lipolytica, the CRISPR-Cas9 system was used to efficiently perform genome alteration, in 280 most articles it was used as LEU2 selection marker, and the PCR technique was used to confirm the 281 alteration of the genome. ; The transformation protocols in the four articles were very similar to each 282 other and are a very useful tool to evaluate the efficiency of these protocols in other yeast species. 283 Schizosaccharomyces pombe: It is a yeast highly studied at an industrial and clinical level together with 284 S. cerevisiae, which is widely used at an industrial level for the fermentation of alcoholic beverages 285 such as rum, tequila, and artisan beverages such as Cachaça in Brazil [31]. It is also a yeast used in 286 the wine industry due to its ability to use malic acid and thus reduce the acidity of wine [32]. In 287 addition, it is a fully sequenced microorganism which allows biotechnological studies. 288

289
Jacobs JZ y cola in 2018 at the State University of New Jersey developed a CRISPR-Cas9 system that 290 allowed the genome editing in S. pombe. They published the ade6 gene, being mutated causes the 291 accumulation of a red precursor in media with low adenine content to be able to identify the 292 transformed cells, concluded that the CRISPR-Cas9 mutagenesis achieves an almost complete 293 efficiency and eliminates the need for selectable markers. The only vector that expresses Cas9 and 294 sgRNA is marked with URA4, which allows the elimination of the plasmid by selection with 5-295 fluoroorotic acid and allows the subsequent mutagenesis of additional targets. The built-in rrk1 / 296 Hammerhead Ribozyme cassette, expressed in Pol II, is useful in other situations where RNA 297 expression and defined arbitrary sequences, such as siRNA or lincRNA, is needed and represents an 298 advantage over Pol III RNA systems. The methods and reagents presented here are useful for 299 genomic research in S. pombe by allowing rapid and specific genome editing [33]. 300 In 2018, they described the CRISPR-Cas9 system to rapidly introduce deletions in the DNA regions 301 that serve as auxotrophic markers in S. pombe, these were: leu1-D0, his3-D0 and lys9-D0, ura4-D18.

302
This system consists of a Cas9 gRNA expression vector and a pair of donor DNA plasmids for each 303 deletion. In addition, they reorganized the essential components in the commonly used pREP 304 plasmid series and assembled the corresponding auxotrophic marker gene in these plasmids [34]. 305 The developed a cloning-free procedure that uses DNA repair in fission S. pombe cells to assemble 306 two linear DNA fragments was performed in 2018 in Beijing, used a circular plasmid encoding Cas9 307 and an amplified sgRNA insert by PCR, both fragments contain only a portion of the URA4 or bsdMX 308 marker, so that only the properly assembled plasmid can confer prototrophy (ability to grow on 309 minimal medium) of uracil or resistance to blasticidin in transformed yeast [35]. In this study they 310 showed that CRISPR-Cas9 based on repair and cloning free allows rapid and efficient point mutation, 311 endogenous N-terminal labeling and elimination of the genomic sequence in fission yeast. 312 In the yeast Schizosaccharomyces pombe in recent years have been developed multiple studies that 313 design various protocols and different mutation alternatives through the CRISPR / Cas9 system that 314 facilitate the mutation of the genome and improve its efficiency to develop genomic studies that 315 explain the function of different genes and at the same time can be used for other cellular models. 316

CRISPR-Cas system in atypical yeasts. 317
At present there are described, approximately 900 yeast species, the investigations are focused on a 318 limited number of these species, we wanted to collect some studies on yeasts that are rare as is the 319 case of Pichia pastoris and Saccharomyces pastorianus, specifically in the genomic edition by CRISPR-320 Cas, we reflect an overview of the latest advances in genomic editing in these yeasts, their main 321 applications and the main challenges. 322 Pichia pastoris: reclassified as Komagataella pastoris, widely used today in the biotechnological field for 323 the production of heterologous proteins [36]. In Austria they demonstrated the integration of 324 cassettes with donor DNA without markers in the wild type strain of P. pastoris, which allows new 325 engineering strategies. They tested three variants of Cas9 (Sp Cas9, Pp Cas9, Hs Cas9) available, to 326 be evaluated in the pastorku70 strain of P. pastoris, they wanted to determine if they would need a 327 different level of expression. For the wild-type strain only Hs Cas9 was included and gave the Cas9/ 328 gRNA expression plasmids a Geneticin resistance marker which proved to be a versatile tool for the 329 recycling of markers. The CRSIPR-Cas9 tool can be applied to modify the existing production strains 330 and also open the way for studies of complete genome modification without markers in P. pastoris. 331 In addition, it can be implemented for autonomous replication sequences (ARS) in classic knockout 332 cassettes to guarantee cassette maintenance, especially in cell cycles in the S / G2 phase where HR 333 predominates and, therefore, favor their integration [37].

334
In 2016 the same Austrian research group mentioned above, systematically tested more than 90 335 constructs containing different DNA sequences optimized with Cas9 codons, several gRNA 336 sequences and promoters of Pol III RNA and Pol II RNA (in combination with ribozymes) for the 337 expression of the gRNAs with different promoters of Pol II RNA for the expression of Cas9 and 338 gRNAs, in order to identify the system failures in P. pastoris. They managed to generate an optimized 339 system for this model which allows alter genes, introduce deletions of multiplexed genes and test the 340 targeted integration of homologous DNA cassettes [38]. 341 Saccharomyces pastorianus: it is widely used for brewing and in recent years its interest has been related 342 to certain glycolysis processes. In the Netherlands, a method based on the CRISPR-Cas9 genome 343 editing was designed for the precise elimination of genes (SeATF1 and SeATF2) in S. pastorianus. The 344 cas9 gene expressed from a mobile genetic element was combined in combination with a plasmid-345 transmitted gRNA expression cassette, the expression of a gRNA flanked with Hammerhead 346 ribozymes and delta Delta viruses using the TDH3 promoter dependent on RNA polymerase II 347 successfully led to the precise elimination of the four alleles of SeILV6 in the strain CBS1483, in 348 addition, the expression of two gRNAs flanked by ribozymes separated by a 10 bp linker in a 349 polycistronic matrix successfully led to the simultaneous elimination of SeATF1 and SeATF2 genes, 350 located in two separated chromosomes [39]. The compilation of these studies of editing of the genome 351 by CRISPR-Cas in washes, allowed to consolidate a general vision of the advances of this technology 352 of showing versatility in editing and approaches, which has allowed the creation of a CRISPRi strain 353 collection for more than 99% of the genes needed for fermentative or respiratory growth [40]. 354 The aforementioned studies on the genome edition in yeasts of industrial, biotechnological or clinical 355 interest are of great importance to understand the biology of fungal cells in fermentative processes in 356 the industry, important pathogenic processes for clinical studies or pharmacokinetic processes.

357
CRISP-Cas is a new methodology implemented in yeasts, there is still a lot to explore and learn. 358

Development of various approaches for the use of the CRISPR / Cas system 359
Since 2012, the CRISPR-Cas system has been used for gene editing and its use has been extended to 360 different species. In recent years, methodologies have been designed that use different CRISPR 361 systems depending on the modifications that are to be made in the genome, here we collect some of 362 the genome editing modifications (Table 1). 363 It allows to increase the activation of a gene to overexpress metabolic compounds. Several metabolic engineering targets can be used for optimization and the exploration of synergistic interactions between transcriptional activation, transcriptional interference and gene elimination can be used. [43] CRISPR-Cpf1 Cpf1 It allows to increase the activation of a gene to overexpress metabolic compounds. Several metabolic engineering targets can be used for optimization and the exploration of synergistic interactions between transcriptional activation, transcriptional interference and gene elimination can be used. [44] CRISPR-PCS From the modifications made to CRISPR and its implementation in the edition of the genome in 365 yeasts, we found that the system is very dynamic, adapts to almost any experimental design and 366 can be implemented for any genetic modification that is desired; each of these variants improves 367 the efficiency of the system and facilitates the editing process. 368

Conclusion 370
The CRISPR system is currently one of the most diverse genetic editing systems. It allows gene edition 371 in different organisms as long as an efficient computer design of the sgRNA sequences is available. It 372 will be implemented to achieve the objective of the study, be it to eliminate a gene, make point 373 mutations, express a gene or do the aforementioned in several genes simultaneously. On the other 374 hand, the new kits generated for this system have certain limitations. For example, the Easy-Clone-375 MarkerFree kit designed in Denmark, where they obtained several integration cassettes 376 simultaneously into the yeast genome. 377 One of the major concerns in the use of CRISPR-Cas is the management of modified strains, in most 378 cases, the authors use control points in which they can elucidate the changes made, and in some cases, 379 indicate when they were lost. However, in some investigations the management of these strains is 380 not clear, although CRISPR / CAS is a technology that has provided many benefits in the genome 381 edition thanks to its highly specificity and efficiency compared to the edition of TALENS and SINES. 382 Its rapid evolution leaves little time for ethical and biosecurity controls, since organisms published 383 by this technology could alter ecosystems if they are not properly managed. 384 As underlined in these articles, CRISPR is a widely used tool for better industrial processes, either to 385 increase production or to eliminate some toxic compound that is generated during the production 386 process of some molecule or industrial product in the yeasts are needed to synthesize or ferment 387 them as it is in the case of alcoholic beverages, in addition, in the clinical area this tool has facilitated 388 the study of several genes involved in signaling pathways that confer the yeast, either resistance 389 treatment pharmacology, or confers pathogenicity on the host. Allowing thus generate alternatives 390 for the industry and in clinic to problems that affect the human being. 391

Methodology 393
Search strategy: the PubMed, Lilacs and google academic databases were consulted. The inclusion 394 criteria were all articles that included the CRISPR /Cas system in yeast, date restriction was not used, 395 articles were consulted only in English and Spanish, searches were made through MeSH terms and 396 Boolean operators, the terms of exclusion were other microorganisms different from yeast and other 397 genome editing methodologies. 398 Selection of the articles: it was carried out according to the PRISMA methodology, it consists of a 399 minimum set of elements, based on evidence, to help to present reports of systematic reviews, and it 400 is useful for the critical evaluation of articles. The articles were evaluated and verified independently 401 by four evaluators taking into account the title, summary, and reading of articles (See graphic prism 402 Annex 1). 403 Analysis of articles: The articles were classified according to the type of study, yeast species and 404 CRISPR / CAS technology type. The data was tabulated in the Excel program.